Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 4/20 | 0.35 |
| ▸ | BRD4 | O60885 | 9/20 | 0.34 |
| ▸ | BRD2 | P25440 | 2/20 | 0.34 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.34 |
| ▸ | PDE5A | O76074 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29619001 | 1.00 | ESR1 (0.35) | ESR1ESR2KRASBRD4BRD2 | |
| SCHEMBL31677911 | 0.88 | ESR1 (0.37) | ESR1ESR2KRASFLT3TLR7 | |
| SCHEMBL29619131 | 0.85 | PDE5A (0.36) | ESR1ESR2KRASBRD4BRD2 | |
| SCHEMBL29619165 | 0.82 | FLT3 (0.41) | FLT3PDE5A | |
| SCHEMBL29619114 | 0.80 | WNT3A (0.44) | FLT3 | |
| SCHEMBL29619028 | 0.80 | FLT3 (0.41) | KRASFLT3 | |
| SCHEMBL29619066 | 0.79 | HTR2A (0.40) | FLT3 | |
| SCHEMBL29619067 | 0.79 | HTR2A (0.40) | FLT3 | |
| SCHEMBL24398370 | 0.77 | BRD4 (0.47) | ESR1ESR2BRD4BRD2BRD3 | |
| SCHEMBL29619004 | 0.75 | BRD4 (0.49) | BRD4BRD2BRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4236942-A1 | ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2022093850-A1 | ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2022-05-05 | — | — | WO | disclosed |